Compounds > grepafloxacin

Page last updated: 2024-08-25

grepafloxacin and cyclosporine

grepafloxacin has been researched along with cyclosporine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	3 (50.00)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Hashimoto, Y; Inui, K; Ito, T; Matsuo, Y; Yano, I	1
Hashimoto, Y; Inui, KI; Yamaguchi, H; Yano, I	1
Inui, K; Saito, H; Yamaguchi, H; Yano, I	2

Other Studies

6 other study(ies) available for grepafloxacin and cyclosporine

Article	Year
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Transport of quinolone antibacterial drugs in a kidney epithelial cell line, LLC-PK1. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:2 Topics: 4-Chloromercuribenzenesulfonate; Animals; Anti-Infective Agents; Cyclosporine; Epithelial Cells; Fluoroquinolones; Hydrogen-Ion Concentration; Kidney; Levofloxacin; LLC-PK1 Cells; Ofloxacin; Piperazines; Quinolones; Swine	1998
Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2. The Journal of pharmacology and experimental therapeutics, 2000, Volume: 295, Issue:1 Topics: Anti-Infective Agents; Biological Transport; Caco-2 Cells; Cyclosporine; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Intestinal Mucosa; Levofloxacin; Metabolic Clearance Rate; Ofloxacin; Piperazines	2000
Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2. European journal of pharmacology, 2001, Nov-23, Volume: 431, Issue:3 Topics: Adenosine Triphosphate; Anti-Infective Agents; Biological Transport; Caco-2 Cells; Carbon Radioisotopes; Chlorides; Cyclosporine; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Levofloxacin; Ofloxacin; Piperazines	2001
Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:3 Topics: Animals; Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile; Biological Availability; Cyclosporine; Enzyme Inhibitors; Fluoroquinolones; Genes, MDR; Intestinal Mucosa; Kidney; Levofloxacin; Liver; Male; Mice; Mice, Knockout; Ofloxacin; Piperazines; Rats; Tissue Distribution	2002